PURPOSE Data confirm that high rates of human papillomavirus (HPV) vaccination have not
been achieved despite strong clinician endorsement of the vaccine. We conducted a study …

Abstract Background In the United States, the effective, safe huma papilloma virus (HPV)
vaccine is underused and opportunities to prevent cancer continue to be missed. National …

The human papillomavirus (HPV) vaccine is an important tool for cancer prevention.
However, vaccination rates in Alabama, a state with high rates of HPV-related cancers …

Introduction Human papillomavirus (HPV) vaccine coverage in the US is persistently
suboptimal, despite research describing barriers to vaccination and strategies to increase …

Objectives HPV vaccination rates in the United States lag behind other developed countries.
Educational interventions are primarily directed at patients and parents rather than …

To examine health providers' perceived barriers, supports, and vaccination actions in
delivering the HPV vaccine to females ages 9–17 in four states. Differences in providers' …

Background Physician recommendation is a key predictor of human papillomavirus (HPV)
vaccine uptake. Understanding factors associated with recommendation is important for …

Provider communication can be critically important to families as they consider HPV
vaccination. We sought to characterize the association of provider communication and HPV …

Human Papillomavirus (HPV) is the most common sexually transmitted infection (STI) in the
United States. Despite numerous studies proving the safety and efficacy of the HPV vaccine …

Objective This study examined patient-, care team-and clinic-level factors associated with
human papillomavirus (HPV) vaccine initiation and completion. Methods HPV vaccine …